191 related articles for article (PubMed ID: 37312839)
1. Development of Oligomeric Mannose-6-phosphonate Conjugates for Targeted Protein Degradation.
Stevens CM; Zhou Y; Teng P; Rault LN; Liao Y; Tang W
ACS Med Chem Lett; 2023 Jun; 14(6):719-726. PubMed ID: 37312839
[TBL] [Abstract][Full Text] [Related]
2. Engineered therapeutic antibodies with mannose 6-phosphate analogues as a tool to degrade extracellular proteins.
Daurat M; Gauthier C; El Cheikh K; Ali LMA; Morère E; Bettache N; Gary-Bobo M; Morère A; Garcia M; Maynadier M; Basile I
Front Immunol; 2024; 15():1273280. PubMed ID: 38533506
[TBL] [Abstract][Full Text] [Related]
3. Conjugation with glucagon like peptide-1 enables targeted protein degradation.
Zhu L; Zhou Y; Zhang B; Luo Y; Fang C; Yan X; Cai Y; Jiang L; Ge J
Bioorg Chem; 2023 Dec; 141():106908. PubMed ID: 37827016
[TBL] [Abstract][Full Text] [Related]
4. Lysosome-targeting chimaeras for degradation of extracellular proteins.
Banik SM; Pedram K; Wisnovsky S; Ahn G; Riley NM; Bertozzi CR
Nature; 2020 Aug; 584(7820):291-297. PubMed ID: 32728216
[TBL] [Abstract][Full Text] [Related]
5. IGF2 Peptide-Based LYTACs for Targeted Degradation of Extracellular and Transmembrane Proteins.
Mikitiuk M; Barczyński J; Bielski P; Arciniega M; Tyrcha U; Hec A; Lipińska AD; Rychłowski M; Holak TA; Sitar T
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005242
[TBL] [Abstract][Full Text] [Related]
6. LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation.
Ahn G; Banik SM; Miller CL; Riley NM; Cochran JR; Bertozzi CR
Nat Chem Biol; 2021 Sep; 17(9):937-946. PubMed ID: 33767387
[TBL] [Abstract][Full Text] [Related]
7. LYTACs: An Emerging Tool for the Degradation of Non-Cytosolic Proteins.
Ramadas B; Kumar Pain P; Manna D
ChemMedChem; 2021 Oct; 16(19):2951-2953. PubMed ID: 34296796
[TBL] [Abstract][Full Text] [Related]
8. Aptamer-LYTACs for Targeted Degradation of Extracellular and Membrane Proteins.
Wu Y; Lin B; Lu Y; Li L; Deng K; Zhang S; Zhang H; Yang C; Zhu Z
Angew Chem Int Ed Engl; 2023 Apr; 62(15):e202218106. PubMed ID: 36722696
[TBL] [Abstract][Full Text] [Related]
9. Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras.
Ahn G; Riley NM; Kamber RA; Wisnovsky S; Moncayo von Hase S; Bassik MC; Banik SM; Bertozzi CR
Science; 2023 Oct; 382(6668):eadf6249. PubMed ID: 37856615
[TBL] [Abstract][Full Text] [Related]
10. Expression, purification, and characterization of human mannose-6-phosphate receptor - Extra cellular domain from a stable cell line utilizing a small molecule biomimetic of the mannose-6-phosphate moiety.
Dwyer B; Lundberg D; Iskenderian A; Strack-Logue B; Pescatore B; Norton AW; Xu J; Meiyappan M; Concino MF; Zhang B
Protein Expr Purif; 2020 Jun; 170():105589. PubMed ID: 32027983
[TBL] [Abstract][Full Text] [Related]
11. Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway.
Ahn G; Banik SM; Bertozzi CR
Cell Chem Biol; 2021 Jul; 28(7):1072-1080. PubMed ID: 33770486
[TBL] [Abstract][Full Text] [Related]
12. Site-Specific Chemoenzymatic Conjugation of High-Affinity M6P Glycan Ligands to Antibodies for Targeted Protein Degradation.
Zhang X; Liu H; He J; Ou C; Donahue TC; Muthana MM; Su L; Wang LX
ACS Chem Biol; 2022 Nov; 17(11):3013-3023. PubMed ID: 35316032
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like Growth Factor 2 (IGF2)-Fused Lysosomal Targeting Chimeras for Degradation of Extracellular and Membrane Proteins.
Zhang B; Brahma RK; Zhu L; Feng J; Hu S; Qian L; Du S; Yao SQ; Ge J
J Am Chem Soc; 2023 Nov; 145(44):24272-24283. PubMed ID: 37899626
[TBL] [Abstract][Full Text] [Related]
14. Multivalent Aptamer-Based Lysosome-Targeting Chimeras (LYTACs) Platform for Mono- or Dual-Targeted Proteins Degradation on Cell Surface.
Duan Q; Jia HR; Chen W; Qin C; Zhang K; Jia F; Fu T; Wei Y; Fan M; Wu Q; Tan W
Adv Sci (Weinh); 2024 May; 11(17):e2308924. PubMed ID: 38425146
[TBL] [Abstract][Full Text] [Related]
15. Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins.
Zhou Y; Teng P; Montgomery NT; Li X; Tang W
ACS Cent Sci; 2021 Mar; 7(3):499-506. PubMed ID: 33791431
[TBL] [Abstract][Full Text] [Related]
16. Cation-independent mannose 6-phosphate receptor: From roles and functions to targeted therapies.
Gauthier C; El Cheikh K; Basile I; Daurat M; Morère E; Garcia M; Maynadier M; Morère A; Gary-Bobo M
J Control Release; 2024 Jan; 365():759-772. PubMed ID: 38086445
[TBL] [Abstract][Full Text] [Related]
17. Nano-LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec-10 Signaling Pathway.
Wang K; Yu A; Liu K; Feng C; Hou Y; Chen J; Ma S; Huang L; Dai X
Adv Sci (Weinh); 2023 May; 10(13):e2300288. PubMed ID: 36866919
[TBL] [Abstract][Full Text] [Related]
18. Mannose 6-phosphate receptor-targeting antibodies preserve Fc receptor-mediated recycling.
Gauthier C; Mariot J; Daurat M; Dhommée C; El Cheikh K; Morère E; Depaepe G; Gary-Bobo M; Morère A; Garcia M; Basile I; Gouilleux-Gruart V; Maynadier M
J Control Release; 2023 Jun; 358():465-475. PubMed ID: 37169177
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the Lysosomal Sorting Signals of the Cation-Independent Mannose-6-Phosphate Receptor for Targeted Degradation of Membrane Proteins.
Yu J; Li H; Fang T; Yun C; Liu X; Xu J; Jiang X; Cai X
J Am Chem Soc; 2023 Aug; 145(34):19107-19119. PubMed ID: 37552887
[TBL] [Abstract][Full Text] [Related]
20. Mannose-6-phosphate glycan for lysosomal targeting: various applications from enzyme replacement therapy to lysosome-targeting chimeras.
Seo J; Oh DB
Anim Cells Syst (Seoul); 2022; 26(3):84-91. PubMed ID: 35784393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
